Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Long-Term Debt 2024-2026 | MRNA

Annual FY2024–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$590.0M

Source: 10-KFY2025

From $0 in FY2024 to $590.0M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$590MNot reportedNot reportedNot reported
FY25Not reportedNot reportedNot reported$590M
FY24Not reportedNot reportedNot reported$0

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

N/A

FY2024
$0
FY2025
$590.0M

1 year selected · on the chart

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  1. $590.0M

Long-Term Debt, period by period

PeriodValueChangeSource
FY2025$590.0M—10-K
FY2024$0—10-K

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is Moderna, Inc.'s current long-term debt?

Moderna, Inc. (MRNA) annual long-term debt for 2025 was $590.0M, a Infinity% increase from 2024. Moderna, Inc. long-term debt for the quarter ending March 31, 2026 was $590.0M.

What was Moderna, Inc.'s long-term debt in 2024?

Moderna, Inc. annual long-term debt for 2024 was $0.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)